MedTrace Logo

Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD

NCT02972580 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-08-27

No results posted yet for this study

Summary

Longitudinal prospective observational study. This is a 24-month study with the possibility of extending the data time points. Initially baseline, then 12 and 24 months follow up studies will be completed.

Conditions

Interventions

GENETIC

Genetic characterization

Confirmatory genetic testing for mutation in DMD gene (Carrier Status) for subjects in respective Cohorts

Sponsors & Collaborators

  • Parent Project Muscular Dystrophy

    collaborator OTHER

  • Nationwide Children's Hospital

    lead OTHER

Principal Investigators

  • May Ling Mah, MD · PI

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02972580 on ClinicalTrials.gov